HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SHISEIDO PURENESS SKIN CARE TARGETS WOMEN IN THEIR 20s

This article was originally published in The Rose Sheet

Executive Summary

SHISEIDO PURENESS SKIN CARE TARGETS WOMEN IN THEIR 20s and early 30s with skin types ranging from oily and problem-prone to normal and normal/combination. The 10-SKU line is designed to address the concerns that women in this age group have about their skin such as oil t-zone, blackheads, acne and enlarged pores, in addition to influences including the environment, lack of sleep and stress. Pureness is launching in the U.S. in August, followed by the U.K., France, Italy, Germany, the Netherlands and Spain in September. The products range in price from $15 to $20 suggested retail.

You may also be interested in...



Marketing In Brief

Olay goes holistic: Procter & Gamble expanding Olay skin care line with Ohm bath & body care this summer. Experiential body care products will retail at mass market, but feature a more specialty positioning. Ohm marks departure from current Olay skin care offerings, such as Olay Total Effects, which address anti-aging benefits...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel